Recent Finacing
Recent Raise
Orchard Therapeutics develops ex vivo autologous hematopoietic stem cell gene therapies for rare inherited disorders, advancing registrational programs (ADA‑SCID, MLD, WAS) with hospital and university development partnerships.
